Data contributed to the scientific and clinical rationale for RASolute 302, a pivotal Phase 3 trial in second line treatment ...

PiNACLE pivotal clinical trial evaluating ronde-cel in patients with LBCL in third- or later-line setting on track to report ...

Researcher Jeffrey L. Cummings M.D., ScD, from the Kirk Kerkorian School of Medicine at UNLV, has released his annual report ...

As a critical raw material for our manufacturing operations, media and buffers sit at the heart of the supply chain. On the ...

Epicrispr Biotechnologies (“Epicrispr”), a clinical-stage company pioneering gene-modulating therapies, and Forge Biologics (“Forge”), a leading manufacturer of gene therapies and member of the ...

Comprehending the spate of recent rejections in the cell and gene therapy space may require looking no further than ...

Accelerated drug development expertise. For small startups and academic spinoffs bringing their first molecules to market, ...

Biosimilar formulation development requires navigating around scientific, regulatory, and legal challenges, according to Sung ...

Scientist Elizabeth Ng is clutching a small flask with a clear mixture inside it that she’s just retrieved from inside a ...

Hospitals filled to capacity. Case counts climbing by the hour. Quarantine became routine. It was the beginning of the ...

Evidence shows that research designed with communities — through shared governance, fair compensation, and mutual ...